Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies
Toxicologic Pathology · 2025
DOI: 10.1177/01926233251326089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, 2025. Verfasst von Pierluigi Fant und 9 weiteren Autor:innen. Beteiligte Einrichtung: Charles River Laboratories Safety Assessment, Saint Germain-Nuelles, France. Hauptthemen laut MEDLINE: RNA, Messenger, COVID-19 Vaccines. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
The 2023 annual scientific meeting of the French Society of Toxicologic Pathology (Société Française de Pathologie Toxicologique, SFPT), entitled “mRNA-based technologies: preclinical development and therapeutic applications,” was held in Lyon (France) on May 25 to 26, 2023. The aim of the meeting was to discuss the biology, immunology, and preclinical development of messenger RNA (mRNA)-based vaccines and therapeutics, including immuno-oncology and rare diseases, as well as the regulatory aspect of the COVID-19 vaccines and an overview of the principles and applications of in situ hybridization techniques. This article presents the summary of five lectures along with selected figures, tables, and key literature references on this topic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charles River Laboratories Safety Assessment, Saint Germain-Nuelles, France.
- Sanofi, Montpellier, France.
- Sanofi Vaccine R&D, Marcy-l'Étoile, France.
- Pfizer Inc, Groton, Connecticut, USA.
- Pfizer Inc, Pearl River, New York, USA.
- Charles River Laboratories, Evreux, France.
ORCID-Profile: Pierluigi Fant, Xavier Palazzi, Shambhunath Choudhary, Béatrice E Gauthier
Zitieren
APA
Fant, P., Laurent, S., Desert, P., Combadière, B., Palazzi, X., Choudhary, S., Gervais, F., Broudic, K., Rossi, R., & Gauthier, B. E. (2025). Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies. Toxicologic Pathology. https://doi.org/10.1177/01926233251326089
Vancouver
Fant P, Laurent S, Desert P, Combadière B, Palazzi X, Choudhary S, et al. Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies. Toxicologic Pathology. 2025. doi:10.1177/01926233251326089
BibTeX
@article{Fant2025,
author = {Fant, Pierluigi and Laurent, Sébastien and Desert, Paul and Combadière, Behazine and Palazzi, Xavier and Choudhary, Shambhunath and Gervais, Frédéric and Broudic, Karine and Rossi, Roberta and Gauthier, Béatrice E},
title = {Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies},
journal = {Toxicologic Pathology},
year = {2025},
doi = {10.1177/01926233251326089}
}
EUVIMED